We did not find a significant association between CCDC19 expression levels and patient's age, sex, smoking status, family tumour history, location, tumour size (T classification), lymph node metastasis (N classification), distant metastasis (N classification) or clinical stage (I-II versus III-IV) in 73 NSCLC patients. This evidence concerns the gene CFAP45 and neoplasm.